Strides Arcolab Ltd (STAR.NS)

STAR.NS on National Stock Exchange of India

1,274.55INR
31 Jul 2015
Change (% chg)

Rs16.65 (+1.32%)
Prev Close
Rs1,257.90
Open
Rs1,267.40
Day's High
Rs1,289.80
Day's Low
Rs1,263.00
Volume
481,263
Avg. Vol
532,394
52-wk High
Rs1,337.00
52-wk Low
Rs542.65

STAR.NS

Chart for STAR.NS

About

Strides Arcolab Limited (Strides) is an India-based global pharmaceutical company. The Company develops and manufactures a range of intellectual property (IP)-led pharmaceutical products. The Company’s business division includes Pharma Generics, Branded Generics, Institutional Business and Bio-Generics. The Company’s Pharma... (more)

Overall

Beta: 0.74
Market Cap(Mil.): Rs75,003.07
Shares Outstanding(Mil.): 59.63
Dividend: 3.00
Yield (%): 0.24

Financials

  STAR.NS Industry Sector
P/E (TTM): 10.36 36.75 40.14
EPS (TTM): 121.47 -- --
ROI: 26.16 16.48 15.75
ROE: 41.93 17.28 16.79
Search Stocks

UPDATE 1-India's Strides to buy Australia, Mauritius drug assets from Aspen for $300 mln

MUMBAI, May 21 - Indian drugmaker Strides Arcolab Ltd has agreed to buy businesses in Australia and Mauritius from South Africa's Aspen Pharmacare Holdings Ltd , paying $300 million to expand its footprint in markets set for brisk growth.

21 May 2015

India's Strides Arcolab to buy some Australia drug assets from Aspen Pharmacare

MUMBAI, May 21 - Indian drugmaker Strides Arcolab Ltd said on Thursday it has agreed to buy a generic drugs business in Australia from South Africa's Aspen Pharmacare Holdings Ltd for about A$380 million ($299.90 million).

21 May 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Axis Capital Limited
$242.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks